Director Mattaj comments on the Nobel Prize for Chemistry 2020
Director Iain Mattaj commented the winners of the 2020 Nobel Prize for Chemistry: “The Nobel prize awarded to Charpentier and Doudna is very well deserved. CRISPR is a typical example of a discovery which initially seemed interesting to a limited, niche group of scientists studying bacterial evolution. It has since become a fundamental tool for biology and subsequently an experimental tool for therapies linked to human health.
Genetic engineering, first achieved in 1972, is the ability to manipulate the structure and composition of DNA molecules by “cutting and pasting”. It allows us to learn what genes do, how they work and why they go wrong.
CRISPR technology has the potential to make the “dream” of genetic engineering come true: to make specific, targeted changes in the genome of any organism.
Since the breakthrough of Charpentier and Doudna, thousands of experiments have been published showing that CRISPR systems work to enable “cut and paste” experiments in the genomes of a large variety of organisms, including human cells and organoids in culture. Off-target side effects are limited and can be measured and controlled. This progress is already enabling clinical trials of the use of CRISPR in certain types of cancer treatment. Once its safety is established, the method will be applicable to many genetic disease states, and also potentially to treat parasites that infect or damage humans, like viruses.
Meanwhile, researchers are applying the method to a wide variety of questions. At Human Technopole for example, we are using it to help understand neurodevelopmental disorders, to identify promising drug targets in different cancers and to understand aspects of the evolution of the brain.”
Image credit: Nobel Media. Ill. Niklas Elmehed.
Share:
You could also like:
-
HT National Facilities: One Year On, New Call Open
On 10 June, Human Technopole marks the one-year anniversary of the official opening of its National Facilities, a key milestone in our mission to support excellence in life sciences across Italy. Celebrating this important date, we are pleased to announce that the new Call for Access to the National Facilities is now open. Researchers can submit their proposals until 30 September 2025.
-
10 Fully Funded PhD Scholarships in Systems Medicine through SEMM
Human Technopole is offering up to 10 fully funded PhD scholarships through the SEMM PhD Program in Systems Medicine. These scholarships are open to talented and motivated graduates—both from Italy and abroad – interested in pursuing doctoral research.
-
Human Technopole Commitment to Gender Equality
Human Technopole is proud to announce the launch of its new Gender Equality Plan (GEP) for 2025-2027, a strategic initiative designed to further integrate gender equality across all aspects of the Institute, building upon the successful outcomes of the previous GEP (2022-2024). HT has also achieved the UNI/PdR 125:2022 certification, which recognizes organizations that promote gender equality and foster inclusive workplaces.
-
2 fully funded PhD fellowships at HT through SISSA
Human Technopole is offering 2 fully funded 4-year PhD fellowships to young scientists from the national and international community who wish to undertake a doctoral degree on a project focused on Computational Biology.
-
Childhood Cancer: Free DNA in Blood Reveals Therapy Resistance
An international study coordinated by Milan’s Human Technopole, the Institute of Cancer Research (ICR) in London, and the Royal Marsden Hospital in London has shown that certain DNA fragments found in the blood of paediatric cancer patients can be used as “biomarkers” to obtain information on the characteristics of the disease and its ability to resist therapies. Analysing these fragments could represent an effective alternative to tumour tissue biopsy, a practice that is particularly difficult in children.